BMX-001 + Chemoradiation for Brain Cancer (BMX-HGG Trial)

"Currently, 209 studies of Radiation Therapy are active in 935 cities and 36 nations. The inaugural study was conducted by Schering-Plough back in 2002 with 60 participants, eventually entering Phase 2 drug approval. Subsequently, 398 trials have been concluded since then."

"In 2002, Memorial Sloan Kettering Cancer Center conducted the first radiation therapy research. To date, 398 trials have been completed with 209 actively recruiting at various sites, particularly in Birmingham Alabama."

"Nitrosourea treatment is frequently administered via Radiation Therapy, however this technique can also be utilized to address mineral supplementation, directives for end-of-life care, and refractory cases of mycosis fungoides."

"At present, there are 9 clinical sites that are enrolling participants. These locations include Birmingham and Durham in addition to San Francisco plus six other hubs. To minimise travelling demands, it is important for those interested to opt for the nearest site possible."

"Unfortunately, this clinical investigation is no longer recruiting new participants. It was first published on September 25th 2018 and last edited nearly four years later on the 26th of September 2022. For those searching for other studies involving glioblastoma there are currently 714 trials open to enrollment, with an additional 209 Radiation Therapy trials in need of patients."

"Our team at Power classified radiation therapy as a level 2 on the safety scale, since there are clinical data that confirms its security but no efficacy studies."

"The research project posted on clinicaltrials.gov is not seeking participants at this juncture, as it has last been updated in September of 2022. However, there are 923 other studies which remain actively recruiting prospective volunteers."